Mutant p53: A therapeutic target for the treatment of triple-negative breast cancer?

被引：0
|
作者：
Synnott, Naoise C.
Pierce, Aisling
Mullooly, Maeve
Caiazza, Francesco
McGowan, Patricia M.
O'Donovan, Norma
Crown, John
Duffy, Michael J.
机构：
[1] Univ Coll Dublin, Educ & Res Ctr, St Vincents Univ Hosp, Dublin 2, Ireland
[2] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[3] Dublin City Univ, Natl Inst Cellular Biotechnol, Mol Therapeut Canc Ireland, Dublin 9, Ireland
[4] Irish Clin Oncol Res Grp, Dublin, Ireland
[5] Mol Therapeut Canc Ireland, Dublin, Ireland
[6] Univ Coll Dublin, Clin Res Ctr, St Vincents Univ Hosp, Dublin 2, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1118
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Ki-67, p53, and clinical outcomes of patients with triple-negative breast cancer
    Nishiyama, Yasuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Arima, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [42] P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
    Pan, Yunbao
    Yuan, Yufen
    Liu, Guoshi
    Wei, Yongchang
    PLOS ONE, 2017, 12 (02):
  • [43] New target identified for the treatment of triple-negative breast cancer
    不详
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (01) : 6 - 6
  • [44] Src: a potential target for the treatment of triple-negative breast cancer
    Tryfonopoulos, D.
    Walsh, S.
    Collins, D. M.
    Flanagan, L.
    Quinn, C.
    Corkery, B.
    McDermott, E. W.
    Evoy, D.
    Pierce, A.
    O'Donovan, N.
    Crown, J.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2234 - 2240
  • [45] Targeting triple negative breast cancer: Is p53 the answer?
    Turner, Natalie
    Moretti, Erica
    Siclari, Olimpia
    Migliaccio, Ilenia
    Santarpia, Libero
    D'Incalci, Maurizio
    Piccolo, Stefano
    Veronesi, Andrea
    Zambelli, Alberto
    Del Sal, Gianni
    Di Leo, Angelo
    CANCER TREATMENT REVIEWS, 2013, 39 (05) : 541 - 550
  • [46] Novel therapeutic strategies in the treatment of triple-negative breast cancer
    Oualla, Karima
    El-Zawahry, Heba M.
    Arun, Banu
    Reuben, James M.
    Woodward, Wendy A.
    El-Din, Heba Gamal
    Lim, Bora
    Mellas, Nawfel
    Ueno, Naoto T.
    Fouad, Tamer M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (07) : 493 - 511
  • [47] Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
    Sainsbury, R.
    Proctor, I.
    Rodriguez, S.
    Loddo, M.
    Tudzarova, S.
    Stoeber, K.
    Williams, G.
    BREAST CANCER RESEARCH, 2010, 12 : S15 - S16
  • [48] Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
    R Sainsbury
    I Proctor
    S Rodriguez
    M Loddo
    S Tudzarova
    K Stoeber
    G Williams
    Breast Cancer Research, 12
  • [49] p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53
    Fojo, T
    DRUG RESISTANCE UPDATES, 2002, 5 (05) : 209 - 216
  • [50] Therapeutic Strategies in Triple-Negative Breast Cancer
    Paradiso, Angelo
    Singer, Christian F.
    BREAST CARE, 2017, 12 (01) : 6 - 7
12345